Status:
COMPLETED
M. Hailey-Hailey: hSPCA1 Expression and Skin Structure Upon Laser Therapy
Lead Sponsor:
Maastricht University Medical Center
Conditions:
Hailey Hailey Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Hailey-Hailey disease is a genetic acantholytic dermatosis characterized by continuous erosion of the skin that results in a burning, painful sensation and restricts the patient in daily life. This di...
Eligibility Criteria
Inclusion
- Inclusion criteria
- 1.Hailey-Hailey patients
- Clinically diagnosed M. Hailey-Hailey as confirmed by histopathology and/or genetic analysis.
- Indication for ablative laser therapy
- \>18 years old
- Informed consent
- 2. Patients without Hailey-Hailey disease
- \>18 years old
- Clinically no symptoms of M. Hailey-Hailey
- Informed consent
Exclusion
- \<18 years old
- Treatment with tetracyclines, topical hormones or oral retinoids within the last 30 days preceding participation
- Lack of informed consent
Key Trial Info
Start Date :
December 21 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 15 2024
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT03849989
Start Date
December 21 2018
End Date
March 15 2024
Last Update
March 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maastricht University Medical Center
Maastricht, Limburg, Netherlands, 6202 AZ